173 related articles for article (PubMed ID: 20127412)
21. Cyclooxygenase-2 expression in canine mammary tumors.
Doré M; Lanthier I; Sirois J
Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
[TBL] [Abstract][Full Text] [Related]
22. VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.
Patruno R; Arpaia N; Gadaleta CD; Passantino L; Zizzo N; Misino A; Lucarelli NM; Catino A; Valerio P; Ribatti D; Ranieri G
J Cell Mol Med; 2009 Mar; 13(3):555-61. PubMed ID: 18429933
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of angiogenesis in canine mammary tumors.
Graham JC; Myers RK
J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
[TBL] [Abstract][Full Text] [Related]
24. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas.
Hargis AM; Ihrke PJ; Spangler WL; Stannard AA
Vet Pathol; 1992 Jul; 29(4):316-28. PubMed ID: 1514218
[TBL] [Abstract][Full Text] [Related]
25. Low-Grade Mammary Gland Tumors in Dogs Have Greater VEGF-A and BMP2 Immunostaining and Higher CD31 Blood Vessel Density.
Franco PIR; Pereira JX; Ferreira HH; de Menezes LB; Miguel MP
Top Companion Anim Med; 2023; 53-54():100778. PubMed ID: 37011834
[TBL] [Abstract][Full Text] [Related]
26. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
27. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
28. Scrotal tumors in dogs: a retrospective study of 676 cases (1986-2010).
Trappler MC; Popovitch CA; Goldschmidt MH; Goldschmidt KH; Risbon RE
Can Vet J; 2014 Jan; 55(1):1229-33. PubMed ID: 24381341
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic characterization of normal and neoplastic canine endothelial cells by lectin histochemistry.
Augustin-Voss HG; Smith CA; Lewis RM
Vet Pathol; 1990 Mar; 27(2):103-9. PubMed ID: 2189254
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of ocular hemangiomas and hemangiosarcomas in dogs.
Chandler HL; Newkirk KM; Kusewitt DF; Dubielzig RR; Colitz CM
Vet Ophthalmol; 2009; 12(2):83-90. PubMed ID: 19261162
[TBL] [Abstract][Full Text] [Related]
32. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
[TBL] [Abstract][Full Text] [Related]
34. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
35. A review of pathological diagnoses made from 87 canine splenic biopsies.
Day MJ; Lucke VM; Pearson H
J Small Anim Pract; 1995 Oct; 36(10):426-33. PubMed ID: 8583757
[TBL] [Abstract][Full Text] [Related]
36. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
Sakalauskaitė S; Riškevičienė V; Šengaut J; Juodžiukynienė N
Acta Vet Scand; 2022 Jun; 64(1):14. PubMed ID: 35761297
[TBL] [Abstract][Full Text] [Related]
37. Deep dermal and subcutaneous canine hemangiosarcoma in the perianal area: diagnosis of perianal mass in a dog.
Choi EW
BMC Vet Res; 2019 Apr; 15(1):115. PubMed ID: 30987633
[TBL] [Abstract][Full Text] [Related]
38. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of P-glycoprotein (PGP) and multidrug resistance-associated protein (MRP) in canine cutaneous mast cell tumors.
Miyoshi N; Tojo E; Oishi A; Fujiki M; Misumi K; Sakamoto H; Kameyama K; Shimizu T; Yasuda N
J Vet Med Sci; 2002 Jun; 64(6):531-3. PubMed ID: 12130841
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
